New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 7, 2012
12:50 EDTELOSSyneron Medical shares should be bought, says Maxim
After Syneron Medical reported weaker than expected Q3 operating results, Maxim believes the outlook for the company in Q4 and 2013 appears to be bright. The firm thinks the aesthetic market is rebounding and it reiterates a Buy rating on the stock.
News For ELOS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
07:13 EDTELOSCanaccord to hold a forum
Subscribe for More Information
November 12, 2014
06:19 EDTELOSSyneron Medical reports Q3 EPS 3c, consensus 3c
Reports Q3 revenue $60.3M, consensus $58.32M. Neutralized for the foreign currency impact, Q3 non-GAAP earnings per share would have been 5c.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use